222 related articles for article (PubMed ID: 27139383)
1. Interoperability Architecture for a Paediatric Oncology European Reference Network.
Nitzlnader M; Canete Nieto A; Ribelles AJ; Brunmair B; Ladenstein R; Schreier G
Stud Health Technol Inform; 2016; 223():39-45. PubMed ID: 27139383
[TBL] [Abstract][Full Text] [Related]
2. Patients' Rights in Cross-border Healthcare (Directive 2011/24/EU) and How It Applies to Turkey as a Negotiating Candidate Country.
Ekmekci PE
Eur J Health Law; 2017; 24(4):432-444. PubMed ID: 29203967
[TBL] [Abstract][Full Text] [Related]
3. Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes.
Vos JR; Giepmans L; Röhl C; Geverink N; Hoogerbrugge N;
Fam Cancer; 2019 Apr; 18(2):281-284. PubMed ID: 30302652
[TBL] [Abstract][Full Text] [Related]
4. European Reference Networks and Guideline Development and Use: Challenges and Opportunities.
Morciano C; Laricchiuta P; Taruscio D; Schünemann H
Public Health Genomics; 2015; 18(5):318-20. PubMed ID: 26227062
[TBL] [Abstract][Full Text] [Related]
5. The European Union Policy in the Field of Rare Diseases.
Moliner AM; Waligora J
Adv Exp Med Biol; 2017; 1031():561-587. PubMed ID: 29214592
[TBL] [Abstract][Full Text] [Related]
6. The European union policy in the field of rare diseases.
Montserrat Moliner A; Waligóra J
Public Health Genomics; 2013; 16(6):268-77. PubMed ID: 24503587
[TBL] [Abstract][Full Text] [Related]
7. European Reference networks for rare diseases: what is the conceptual framework?
Héon-Klin V
Orphanet J Rare Dis; 2017 Aug; 12(1):137. PubMed ID: 28784158
[TBL] [Abstract][Full Text] [Related]
8. [European Reference Networks : Consequences for healthcare in Germany].
Graessner H; Schäfer F; Scarpa M; Wagner TOF
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):537-541. PubMed ID: 28275837
[TBL] [Abstract][Full Text] [Related]
9. The European Paediatric Rare Tumours Network - European Registry (PARTNER) project for very rare tumors in children.
Orbach D; Ferrari A; Schneider DT; Reguerre Y; Godzinski J; Bien E; Stachowicz-Stencel T; Surun A; Almaraz RL; Dragomir M; Jani D; Ami TB; Roganovic J; Brecht IB; Ladenstein R; Bisogno G
Pediatr Blood Cancer; 2021 Jun; 68 Suppl 4():e29072. PubMed ID: 33913610
[TBL] [Abstract][Full Text] [Related]
10. Ethical assessment of the EU health policy under the Directive 2011∕24∕EU: approaching patients' rights and cross-border healthcare.
Olimid AP; Olimid DA
Rom J Morphol Embryol; 2019; 60(2):729-735. PubMed ID: 31658352
[TBL] [Abstract][Full Text] [Related]
11. [Healthcare networks for people with rare diseases: integrating data and expertise].
Graessner H; Storf H; Schaefer F
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Nov; 65(11):1164-1169. PubMed ID: 36167994
[TBL] [Abstract][Full Text] [Related]
12. Creating a European Union framework for actions in the field of rare diseases.
Moliner AM
Adv Exp Med Biol; 2010; 686():457-73. PubMed ID: 20824460
[TBL] [Abstract][Full Text] [Related]
13. ERN BOND: The key European network leveraging diagnosis, research, and treatment for rare bone conditions.
Casareto L; Appelman-Dijkstra NM; Brandi ML; Chapurlat R; Cormier-Daire V; Hamdy NAT; Heath KE; Horn J; Mantovani G; Mohnike K; Sousa SB; Travessa A; Wekre LL; Zillikens MC; Sangiorgi L;
Eur J Med Genet; 2024 Apr; 68():104916. PubMed ID: 38296035
[TBL] [Abstract][Full Text] [Related]
14. Patient mobility in the European Union: pushing for EU internal health market.
Lang IG
Med Law; 2009 Dec; 28(4):661-71. PubMed ID: 20157977
[TBL] [Abstract][Full Text] [Related]
15. Survey on paediatric tumour boards in Europe: current situation and results from the ExPo-r-Net project.
Juan Ribelles A; Berlanga P; Schreier G; Nitzlnader M; Brunmair B; Castel V; Essiaf S; Cañete A; Ladenstein R
Clin Transl Oncol; 2018 Aug; 20(8):1046-1052. PubMed ID: 29313207
[TBL] [Abstract][Full Text] [Related]
16. Free movement of patients: Directive 2011/24 on the application of patients' rights in cross-border healthcare.
Peeters M
Eur J Health Law; 2012 Mar; 19(1):29-60. PubMed ID: 22428388
[TBL] [Abstract][Full Text] [Related]
17. Telemedicine strategy of the European Reference Network ITHACA for the diagnosis and management of patients with rare developmental disorders.
Smith M; Alexander E; Marcinkute R; Dan D; Rawson M; Banka S; Gavin J; Mina H; Hennessy C; Riccardi F; Radio FC; Havlovicova M; Cassina M; Emandi AC; Fradin M; Gompertz L; Nordgren A; Traberg R; Rossi M; Trimouille A; Sowmyalakshmi R; Dallapiccola B; Renieri A; Faivre L; Kerr B; Verloes A; Clayton-Smith J; Douzgou S;
Orphanet J Rare Dis; 2020 Apr; 15(1):103. PubMed ID: 32334637
[TBL] [Abstract][Full Text] [Related]
18. Dream vs. reality: seven case-studies on the desirability and feasibility of cross-border hospital collaboration in Europe.
Glinos IA; Baeten R
Soc Sci Med; 2014 Sep; 117():18-24. PubMed ID: 25025866
[TBL] [Abstract][Full Text] [Related]
19. Cross-border healthcare directive: Assessing stakeholders' perspectives in Poland and Portugal.
Helena R
Health Policy; 2016 Apr; 120(4):369-76. PubMed ID: 26948704
[TBL] [Abstract][Full Text] [Related]
20. The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.
Parker S
Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv9-14. PubMed ID: 25165190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
